Echocardiography in Nursing Home
ECHOGER
Implementation and Effectiveness of Screening Echocardiography Performed in Nursing Home: ECHOGER
1 other identifier
interventional
1,050
1 country
1
Brief Summary
The study seeks to explore the implementation characteristics (acceptability, appropriateness, feasibility, adoption, fidelity, penetration, implementation cost and sustainability) of systematic echocardiography in nursing homes and its impact on rates of heart failure flare-up and unscheduled hospitalization at 12 months among included nursing homes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2024
CompletedFirst Posted
Study publicly available on registry
June 6, 2024
CompletedStudy Start
First participant enrolled
October 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2030
December 3, 2025
December 1, 2025
3.2 years
May 14, 2024
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Count of resident presenting a heart failure decompensation
Number of residents with heart failure flare (worsening of at least 1 NYHA class) or unplanned hospitalization for heart failure
12 months
Secondary Outcomes (1)
Presence of a clinically significative change in medical management and care in the month following ultrasound
12 months
Study Arms (2)
Echocardiographic screening arm
EXPERIMENTALParticipants from nursing homes allocated to echocardiographic screening group will benefit of one echocardiography at inclusion.
Usual care
NO INTERVENTIONParticipants from nursing homes allocated to no-screening group. Participants will be followed for medical management and care as usual.
Interventions
An ultrasound will be carried out in the EHPAD, the result of which will be interpreted by a cardiologist then sent to the establishment and the attending physician with instructions to follow.
Eligibility Criteria
You may qualify if:
- Nursing homes residents with a life-expectancy estimated \> 1 year, and able to participate to the study, giving an oral consent
You may not qualify if:
- no accessible to echocardiography
- closed unit (severe Alzheimer disease…)
- recent contagious disease such Covid (\<15 days)
- no consent to participate
- no social security number
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Directorate of Health Care Supplycollaborator
- Nantes University Hospitallead
Study Sites (1)
Nantes University Hospital
Nantes, Loire-Atlantique, 44093, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thierry LE TOURNEAU, PU-PH
Nantes University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Not relevant
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2024
First Posted
June 6, 2024
Study Start
October 2, 2024
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2030
Last Updated
December 3, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share